Percutaneous circulatory support in cardiogenic shock interventional bridge to recovery

Circulation

Volumn 125, Issue 14, 2012, Pages 1809-1817

  Kar, Biswajit ^a,b,c   Basra, Sukhdeep S ^a   Shah, Nishant R ^a,b   Loyalka, Pranav ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Balloon; Cardiopulmonary resuscitation; Extracorporeal circulation; Heart failure; Heart assist devices; Myocardial infarction; Revascularization

Indexed keywords

AORTA BALLOON; ARTICLE; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CATHETER ABLATION; COUNTERPULSATION; HEART ASSIST DEVICE; HEART VENTRICLE TACHYCARDIA; PATHOPHYSIOLOGY; PATIENT SELECTION; PATIENT TRANSPORT; PERCUTANEOUS VENTRICULAR ASSIST DEVICE; PRIORITY JOURNAL; WEANING;

EXTRACORPOREAL MEMBRANE OXYGENATION; HEART-ASSIST DEVICES; HUMANS; INTRA-AORTIC BALLOON PUMPING; PATIENT SELECTION; SHOCK, CARDIOGENIC; TIME FACTORS;

EID: 84859556875     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.040220     Document Type: Article

References (63)

1. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909-2945.
2. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294:448-454. (Pubitemid 41124177)
3. Hasdai D, Harrington RA, Hochman JS, Califf RM, Battler A, Box JW, Simoons ML, Deckers J, Topol EJ, Holmes DR Jr. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol. 2000;36:685-692.
4. Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117:686-697.
5. Samuels LE, Kaufman MS, Thomas MP, Holmes EC, Brockman SK, Wechsler AS. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. JCard Surg. 1999;14:288-293. (Pubitemid 30418442)
6. Kirklin JK, Frazier OH. Developmental history of mechanical circulatory support. Mechanical Circulatory Support. Addison, TX: International Society for Heart and Lung Transplantation; 2006. ISHLT Monograph Series, volume 1.
7. Scheidt S, Wilner G, Mueller H, Summers D, Lesch M, Wolff G, Krakauer J, Rubenfire M, Fleming P, Noon G, Oldham N, Killip T, Kantrowitz A. Intra-aortic balloon counterpulsation in cardiogenic shock: report of a co-operative clinical trial. N Engl J Med. 1973;288:979-984.
8. Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, Dens J, Dzavik V, Palmeri ST, Webb JG, Goldberger M, Hochman JS. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry: Should We Emer-gently Revascularize Occluded Coronaries for Cardiogenic Shock? J Am Coll Cardiol. 2000;36:1123-1129.
9. Anderson RD, Ohman EM, Holmes DR Jr, Col I, Stebbins AL, Bates ER, Stomel RJ, Granger CB, Topol EJ, Califf RM. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: Obser-vations from the GUSTO-I study: Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30: 708-715. (Pubitemid 27397651)
10. Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, Chou TM. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the national registry of myocardial infarction 2. Am Heart J. 2001; 141:933-939.
11. Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, Russ M, Schlitt A, Buerke U, Christoph A, Schmidt H, Winkler M, Thiery J, Werdan K, Buerke M. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP Shock Trial for Attenuation of Multiorgan Dysfunction Syndrome. Crit Care Med. 2010;38:152-160.
12. Unverzagt S, Machemer MT, Solms A, Thiele H, Burkhoff D, Seyfarth M, de Waha A, Ohman EM, Buerke M, Haerting J, Werdan K, Prondzinsky R. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev. 2011;7:CD007398.
13. Sjauw KD, Engstrom AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009;30:459-468.
14. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110:e82-e292.
15. Champsaur G, Ninet J, Vigneron M, Cochet P, Neidecker J, Boissonnat P. Use of the Abiomed BVS system 5000 as a bridge to cardiac trans-plantation. J Thorac Cardiovasc Surg. 1990;100:122-128. (Pubitemid 20213611)
16. Dekkers RJ, Fitz Gerald DJ, Couper GS. Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure. Perfusion. 2001;16:13-18. (Pubitemid 32042183)
17. De Robertis F, Birks EJ, Rogers P, Dreyfus G, Pepper JR, Khaghani A. Clinical performance with the Levitronix Centri Mag short-term ventric-ular assist device. J Heart Lung Transplant. 2006;25:181-186. (Pubitemid 43156369)
18. John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ, Frazier OH, Joyce LD. Outcomes of a multicenter trial of the Levitronix Cen-tri Mag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932-939.
19. Thomas HL, Dronavalli VB, Parameshwar J, Bonser RS, Banner NR. Incidence and outcome of Levitronix Centri Mag support as rescue therapy for early cardiac allograft failure: a United Kingdom national study. Eur J Cardiothorac Surg. 2011;6:1348-1354.
20. Aziz TA, Singh G, Popjes E, Stephenson E, Mulvey S, Pae W, El-Banayosy A. Initial experience with Centri Mag extracorporal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. JHeart Lung Transplant. 2010;29:66-71.
21. La Rocca GM, Shimbo D, Rodriguez CJ, Stewart A, Naka Y, Weinberger J, Homma S, Pizzarello R. The Impella Recover LP 5.0 left ventricular assist device: a bridge to coronary artery bypass grafting and cardiac transplantation. J Am Soc Echocardiogr. 2006;19:468 e465-e467.
22. Samoukovic G, Rosu C, Giannetti N, Cecere R. The Impella LP 5.0 as a bridge to long-term circulatory support. Interact Cardiovasc Thorac Surg. 2009;8:682-683.
23. Samoukovic G, Al-Atassi T, Rosu C, Giannetti N, Cecere R. Successful treatment of heart failure due to acute transplant rejection with the Impella LP 5.0. Ann Thorac Surg. 2009;88:271-273.
24. Andrade JG, Al-Saloos H, Jeewa A, Sandor GG, Cheung A. Facilitated cardiac recovery in fulminant myocarditis: pediatric use of the Impella 5.0 pump. JHeart Lung Transplant. 2010;29:96-97.
25. Wampler RK, Baker BA, Wright WM. Circulatory support of cardiac interventional procedures with the Hemopump cardiac assist system. Cardiology. 1994;84:194-201. (Pubitemid 24087077)
26. Wittenmyer BL, Pomerants BJ, Duff SB, Watson WD, Blackford JM. Single hospital experience with emergency cardiopulmonary bypass using the portable CPS (Bard) system. J Extra Corpor Technol. 1997;29: 73-77. (Pubitemid 27284162)
27. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the Tandem Heart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152:469.e1-469.e8.
28. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascu-larized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276-1283. (Pubitemid 41435457)
29. Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011;57:688-696.
30. Bruckner BA, Jacob LP, Gregoric ID, Loyalka P, Kar B, Cohn WE, La Francesca S, Radovancevic B, Frazier OH. Clinical experience with the Tandem Heart percutaneous ventricular assist device as a bridge to cardiac transplantation. Tex Heart Inst J. 2008;35:447-450.
31. Gregoric ID, Jacob LP, La Francesca S, Bruckner BA, Cohn WE, Loyalka P, Kar B, Frazier OH. The Tandem Heart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge). Tex Heart Inst J. 2008; 35:125-129. (Pubitemid 351988639)
32. Brinkman WT, Rosenthal JE, Eichhorn E, Dewey TM, Magee MJ, Savor DS, Riley AG, Prince SL, Worley CM, Herbert MA, Mack MJ. Role of a percutaneous ventricular assist device in decision making for a cardiac transplant program. Ann Thorac Surg. 2009;88:1462-1466.
33. Chandra D, Kar B, Idelchik G, Simpson L, Loyalka P, Gregoric ID, Delgado RM 3rd, Frazier OH. Usefulness of percutaneous left ventricular assist device as a bridge to recovery from myocarditis. Am J Cardiol. 2007;99:1755-1756. (Pubitemid 46874330)
34. Giesler GM, Gomez JS, Letsou G, Vooletich M, Smalling RW. Initial report of percutaneous right ventricular assist for right ventricular shock secondary to right ventricular infarction. Catheter Cardiovasc Interv. 2006;68:263-266. (Pubitemid 44167680)
35. Atwater BD, Nee LM, Gimelli G. Long-term survival using intra-aortic balloon pump and percutaneous right ventricular assist device for biven-tricular mechanical support of cardiogenic shock. J Invasive Cardiol. 2008;20:E205-E207.
36. Rajagopal V, Steahr G, Wilmer CI, Raval NY. A novel percutaneous mechanical biventricular bridge to recovery in severe cardiac allograft rejection. JHeart Lung Transplant. 2010;29:93-95.
37. Takagaki M, Wurzer C, Wade R, Lee R, Malaisrie SC, McCarthy PM, McGee EC Jr. Successful conversion of Tandem Heart left ventricular assist device to right ventricular assist device after implantation of a Heartmate XVE. Ann Thorac Surg. 2008;86:1677-1679.
38. Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, Dirschinger J, Kastrati A, Schomig A. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52: 1584-1588.
39. Engstrom AE, Cocchieri R, Driessen AH, Sjauw KD, Vis MM, Baan J, de Jong M, Lagrand WK, van der Sloot JA, Tijssen JG, de Winter RJ, de Mol BA, Piek JJ, Henriques JP. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience. Crit Care Med. 2011;9:2072-2079.
40. Wiktor DM, Sawlani N, Kanthi Y, Sipahi I, Fang JC, Blitz A. Successful combined use of Impella Recover 2.5 device and intra-aortic balloon pump support in cardiogenic shock from acute myocardial infarction. ASAIO J. 2010;56:519-521.
41. Gupta A, Allaqaband S, Bajwa T. Combined use of Impella device and intra-aortic balloon pump to improve survival in a patient in profound cardiogenic shock post cardiac arrest. Catheter Cardiovasc Interv. 2009; 74:975-976.
42. Doll N, Kiaii B, Borger M, Bucerius J, Kramer K, Schmitt DV, Walther T, Mohr FW. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative car-diogenic shock. Ann Thorac Surg. 2004;77:151-157. (Pubitemid 38130002)
43. Asaumi Y, Yasuda S, Morii I, Kakuchi H, Otsuka Y, Kawamura A, Sasako Y, Nakatani T, Nonogi H, Miyazaki S. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Eur Heart J. 2005;26:2185-2192. (Pubitemid 41408005)
44. Sheu JJ, Tsai TH, Lee FY, Fang HY, Sun CK, Leu S, Yang CH, Chen SM, Hang CL, Hsieh YK, Chen CJ, Wu CJ, Yip HK. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary inter-vention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med. 2010;38:1810-1817.
45. Gariboldi V, Grisoli D, Tarmiz A, Jaussaud N, Chalvignac V, Kerbaul F, Collart F. Mobile extracorporeal membrane oxygenation unit expands cardiac assist surgical programs. Ann Thorac Surg. 2010;90:1548-1552.
46. Arlt M, Philipp A, Voelkel S, Camboni D, Rupprecht L, Graf BM, Schmid C, Hilker M. Hand-held minimised extracorporeal membrane oxygenation: a new bridge to recovery in patients with out-of-centre cardiogenic shock. Eur J Cardiothorac Surg. 2011;40:689-694.
47. Jung C, Schlosser M, Figulla HR, Ferrari M. Providing macro- and microcirculatory support with the Lifebridge system during high-risk PCI in cardiogenic shock. Heart Lung Circ. 2009;18:296-298.
48. Conzelmann LO, Mehlhorn U, Weigang E, Kayhan N, Vahl CF. Suc-cessful management of fulminant pulmonary embolism using a novel portable extracorporeal life support system. Ann Thorac Surg. 2011;91: 1265-1267.
49. Smith EJ, Reitan O, Keeble T, Dixon K, Rothman MT. A first-in-man study of the Reitan catheter pump for circulatory support in patients undergoing high-risk percutaneous coronary intervention. Catheter Cardiovasc Interv. 2009;73:859-865.
50. Amico A, Brigiani MS, Vallabini A, Ferrante B, Marzovillo A, Loizzi D, Carbone C. Pulsecath, a new short-term ventricular assist device: our expe-rience in off-pump coronary artery bypass graft surgery. J Cardiovasc Med (Hagerstown). 2008;9:423-426. (Pubitemid 351374278)
51. Arrigoni SC, Kuijpers M, Mecozzi G, Mariani MA. Pulsecath® as a right ventricular assist device. Interact Cardiovasc Thorac Surg. 2011;12: 891-894.
52. Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010;304:867-874.
53. Fonger JD, Zhou Y, Matsuura H, Aldea GS, Shemin RJ. Enhanced preservation of acutely ischemic myocardium with transseptal left ven-tricular assist. Ann Thorac Surg. 1994;57:570-575. (Pubitemid 24114947)
54. Meyns B, Stolinski J, Leunens V, Verbeken E, Flameng W. Left ventric-ular support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol. 2003;41:1087-1095. (Pubitemid 36384893)
55. Dixon SR, Henriques JP, Mauri L, Sjauw K, Civitello A, Kar B, Loyalka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O'Neill WW. A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percu-taneous Coronary Intervention (the PROTECT I trial): initial U.S. expe-rience. J Am Coll Cardiol Cardiovasc Interv. 2009;2:91-96.
56. Syed AI, Kakkar A, Torguson R, Li Y, Ben-Dor I, Collins SD, Lemesle G, Maluenda G, Xue Z, Scheinowitz M, Kaneshige K, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary inter-vention: will the Impella LP 2.5 device show superiority in a clinical randomized study? Cardiovasc Revasc Med. 2010;11:91-97.
57. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden HH, Butter C, Engstrom T, Hassager C, Machado FP, Pedrazzini G, Wagner DR, Schamberger R, Kerber S, Mathey DG, Schofer J, Engstrom AE, Henriques JP. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device: the Europella registry. J Am Coll Cardiol. 2009;54:2430-2434.
58. Kar B, Forrester M, Gemmato C, Civitello A, Loyalka P, Myers T, Delgado R. Use of the Tandem Heart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. JInvasive Cardiol. 2006;18:A6.
59. Vranckx P, Meliga E, De Jaegere PP, Van den Ent M, Regar ES, Serruys PW. The Tandem Heart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions: the six-year Rotterdam experience. Euro Intervention. 2008;4:331-337.
60. Friedman PA, Munger TM, Torres N, Rihal C. Percutaneous endocardial and epicardial ablation of hypotensive ventricular tachycardia with per-cutaneous left ventricular assist in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 2007;18:106-109. (Pubitemid 44952755)
61. Abuissa H, Roshan J, Lim B, Asirvatham SJ. Use of the Impella microaxial blood pump for ablation of hemodynamically unstable ven-tricular tachycardia. J Cardiovasc Electrophysiol. 2010;21:458-461.
62. Tallaj JA, Cadeiras M. Mechanicalrescue of theheart in shock. J Am Coll Cardiol. 2011;57:697-699.
63. Demirozu ZT, Ho J, Bogaev RC, Lemaire SA, Coselli JS, Frazier OH. Thrombotic occlusion of an aortic-root xenograft during left ventricular assistance. Tex Heart Inst J. 2011;38:66-67.